<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02150954</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00001312</org_study_id>
    <nct_id>NCT02150954</nct_id>
  </id_info>
  <brief_title>Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor</brief_title>
  <official_title>A Randomized Comparison of Foley Bulb With Low Dose Pitocin Versus Foley Bulb With a Standard Incremental Infusion Protocol for the Induction of Labor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Duke University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Duke University</source>
  <brief_summary>
    <textblock>
      The purpose of this research study is to compare induction of labor using a foley catheter
      bulb with a low dose of oxytocin versus a foley catheter bulb with an increasing dose of
      oxytocin. A foley catheter bulb with or without oxytocin is a common method of labor
      induction in patients whose cervix is not significantly dilated or thinned out (effaced).
      Oxytocin (pitocin) is a medicine used to increase the number and strength of the womb's
      contractions.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2007</start_date>
  <completion_date type="Actual">March 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to the Second Stage of Labor</measure>
    <time_frame>foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)</time_frame>
    <description>The second stage of labor was defined as the time from complete cervical dilation to delivery of the fetus.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to Delivery</measure>
    <time_frame>foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)</time_frame>
    <description>Time from foley balloon placement until neonate delivery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of Cesarean Delivery</measure>
    <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
    <description>Number of participants having a cesarean delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Active Labor</measure>
    <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
    <description>Active labor was defined as the presence of regular, painful contractions and a minimum of 2 cm cervical dilation and complete effacement in nulliparous women or a minimum of 4 cm cervical dilation in multiparous women.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Foley Expulsion or Removal</measure>
    <time_frame>foley bulb placement until removal, up to 10 hours</time_frame>
    <description>Time from foley balloon placement until the expulsion or removal of the foley balloon.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Uterine Hyperstimulation</measure>
    <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
    <description>Uterine hyperstimulation (tachysystole) was defined as uterine contractions occurring greater than 12 in 20 minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Outcome: Birthweight</measure>
    <time_frame>at time of birth (0 to 1 hour)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Outcome: Placental Abruption</measure>
    <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
    <description>number of participants with placental abruption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Outcome: Late Fetal Heart Rate Decelerations</measure>
    <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
    <description>Late fetal heart rate decelerations were defined as a gradual decrease in the fetal heart rate associated with uterine contraction with the nadir of the deceleration occurring after the peak of the contraction.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">121</enrollment>
  <condition>Induction of Labor</condition>
  <arm_group>
    <arm_group_label>foley bulb induction with low dose pitocin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>foley bulb with standard incremental pitocin infusion protocol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pitocin</intervention_name>
    <arm_group_label>foley bulb induction with low dose pitocin</arm_group_label>
    <arm_group_label>foley bulb with standard incremental pitocin infusion protocol</arm_group_label>
    <other_name>oxytocin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients with a singleton pregnancy

          2. Term pregnancy (&gt; 37 weeks gestation)

          3. Age â‰¥ 18 years

          4. Bishop score &lt; 5

          5. Contractions &lt; 6/hr

          6. Reassuring fetal heart tracing

        Exclusion Criteria:

          1. Rupture of membranes

          2. Antepartum bleeding

          3. Fetal death

          4. Placenta previa or low lying placenta

          5. Active genital herpes infection

          6. Previous use of an induction or preinduction agent during the current pregnancy

          7. EFW &gt;4500 grams

          8. Non reassuring fetal testing

          9. Inability to pass foley through cervix

         10. Prior cesarean section
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chad Grotegut, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brennan Fitzpatrick, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2014</study_first_submitted>
  <study_first_submitted_qc>May 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 30, 2014</study_first_posted>
  <results_first_submitted>June 24, 2014</results_first_submitted>
  <results_first_submitted_qc>June 24, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 23, 2014</results_first_posted>
  <last_update_submitted>August 4, 2014</last_update_submitted>
  <last_update_submitted_qc>August 4, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 6, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>induction of labor</keyword>
  <keyword>pitocin</keyword>
  <keyword>foley bulb</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>121 subjects enrolled. Of the 121 subjects 2 were screen failures and 2 subject were excluded after consent due to meeting exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Foley Bulb Induction With Low Dose Pitocin</title>
          <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
        </group>
        <group group_id="P2">
          <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
          <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="57"/>
                <participants group_id="P2" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Foley Bulb Induction With Low Dose Pitocin</title>
          <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
        </group>
        <group group_id="B2">
          <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
          <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="57"/>
            <count group_id="B2" value="59"/>
            <count group_id="B3" value="116"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to the Second Stage of Labor</title>
        <description>The second stage of labor was defined as the time from complete cervical dilation to delivery of the fetus.</description>
        <time_frame>foley bulb placement until second stage of labor (during admission for delivery, up to approximately 4 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Time to the Second Stage of Labor</title>
          <description>The second stage of labor was defined as the time from complete cervical dilation to delivery of the fetus.</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.2" lower_limit="13.6" upper_limit="27.8"/>
                    <measurement group_id="O2" value="14.6" lower_limit="9.9" upper_limit="28.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Time to Delivery</title>
        <description>Time from foley balloon placement until neonate delivery</description>
        <time_frame>foley bulb placement until delivery (during admission for delivery, up to approximately 4 days)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Delivery</title>
          <description>Time from foley balloon placement until neonate delivery</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.7" lower_limit="13.8" upper_limit="30.1"/>
                    <measurement group_id="O2" value="19.1" lower_limit="12.1" upper_limit="32.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rate of Cesarean Delivery</title>
        <description>Number of participants having a cesarean delivery</description>
        <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Rate of Cesarean Delivery</title>
          <description>Number of participants having a cesarean delivery</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Active Labor</title>
        <description>Active labor was defined as the presence of regular, painful contractions and a minimum of 2 cm cervical dilation and complete effacement in nulliparous women or a minimum of 4 cm cervical dilation in multiparous women.</description>
        <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Active Labor</title>
          <description>Active labor was defined as the presence of regular, painful contractions and a minimum of 2 cm cervical dilation and complete effacement in nulliparous women or a minimum of 4 cm cervical dilation in multiparous women.</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.3" lower_limit="5.8" upper_limit="22.4"/>
                    <measurement group_id="O2" value="12.2" lower_limit="6.7" upper_limit="23.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Foley Expulsion or Removal</title>
        <description>Time from foley balloon placement until the expulsion or removal of the foley balloon.</description>
        <time_frame>foley bulb placement until removal, up to 10 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Foley Expulsion or Removal</title>
          <description>Time from foley balloon placement until the expulsion or removal of the foley balloon.</description>
          <units>hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" lower_limit="2.7" upper_limit="7.5"/>
                    <measurement group_id="O2" value="5.6" lower_limit="3.3" upper_limit="8.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Uterine Hyperstimulation</title>
        <description>Uterine hyperstimulation (tachysystole) was defined as uterine contractions occurring greater than 12 in 20 minutes.</description>
        <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Uterine Hyperstimulation</title>
          <description>Uterine hyperstimulation (tachysystole) was defined as uterine contractions occurring greater than 12 in 20 minutes.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7"/>
                    <measurement group_id="O2" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Outcome: Birthweight</title>
        <time_frame>at time of birth (0 to 1 hour)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Outcome: Birthweight</title>
          <units>gram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3065" spread="530"/>
                    <measurement group_id="O2" value="3180" spread="511"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Outcome: Placental Abruption</title>
        <description>number of participants with placental abruption</description>
        <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Outcome: Placental Abruption</title>
          <description>number of participants with placental abruption</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Outcome: Late Fetal Heart Rate Decelerations</title>
        <description>Late fetal heart rate decelerations were defined as a gradual decrease in the fetal heart rate associated with uterine contraction with the nadir of the deceleration occurring after the peak of the contraction.</description>
        <time_frame>during admission for delivery, up to approximately 4 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foley Bulb Induction With Low Dose Pitocin</title>
            <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
          </group>
          <group group_id="O2">
            <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
            <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Outcome: Late Fetal Heart Rate Decelerations</title>
          <description>Late fetal heart rate decelerations were defined as a gradual decrease in the fetal heart rate associated with uterine contraction with the nadir of the deceleration occurring after the peak of the contraction.</description>
          <units>neonates</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="57"/>
                <count group_id="O2" value="59"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="14"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Foley Bulb Induction With Low Dose Pitocin</title>
          <description>Subjects in this arm will receive a standard infusion protocol of pitocin starting at 1 milliunit/minute (mius/min) and increasing 2 milliunits per minute every 30 minutes.
pitocin</description>
        </group>
        <group group_id="E2">
          <title>Foley Bulb With Standard Incremental Pitocin Infusion Protocol</title>
          <description>Subjects in this arm will receive a fixed low dose pitocin infusion protocol of 2 mius/min.
pitocin</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="57"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="59"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Chad Grotegut , MD</name_or_title>
      <organization>Duke University Medical Center</organization>
      <email>chad.grotegut@dm.duke.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

